acetylcysteine and Mucositis

acetylcysteine has been researched along with Mucositis in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Algul, E; Celebi, NK; Deveci, HS; Ozturk, SK; Palaoglu, I; Somay, A; Yaprak, G	1
Blanchard, MJ; Foote, RL; Gamez, ME; Garces, YI; Grover, Y; Halyard, MY; Martenson, JA; McGee, LA; Miller, RC; Neben Wittich, MA; Novotny, PJ; Patel, SH; Pederson, LD; Rwigema, JM; Seeger, GR; Sio, TT	1
Cho, SG; Im, KI; Jeon, YW; Kim, N; Lee, ES; Lim, JY; Nam, YS; Song, Y	1
Bowen, JM; Keefe, DM; Sonis, ST	1

Reviews

1 review(s) available for acetylcysteine and Mucositis

Article	Year
Emerging drugs for chemotherapy-induced mucositis. Expert opinion on emerging drugs, 2008, Volume: 13, Issue:3 Topics: Acetylcysteine; Amifostine; Antineoplastic Agents; Drugs, Investigational; Fibroblast Growth Factor 7; Glutamine; Humans; Mucositis; Palliative Care	2008

Trials

1 trial(s) available for acetylcysteine and Mucositis

Article	Year
N-Acetylcysteine Rinse for Thick Secretion and Mucositis of Head and Neck Chemoradiotherapy (Alliance MC13C2): A Double-Blind Randomized Clinical Trial. Mayo Clinic proceedings, 2019, Volume: 94, Issue:9 Topics: Acetylcysteine; Aged; Chemoradiotherapy; Double-Blind Method; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mouth Mucosa; Mouthwashes; Mucositis; Patient Reported Outcome Measures; Patient Safety; Pilot Projects; Prospective Studies; Quality of Life; Reference Values; Risk Assessment; Treatment Outcome; Xerostomia	2019

Article

Year

N-Acetylcysteine Rinse for Thick Secretion and Mucositis of Head and Neck Chemoradiotherapy (Alliance MC13C2): A Double-Blind Randomized Clinical Trial.

Mayo Clinic proceedings, 2019, Volume: 94, Issue:9

Topics: Acetylcysteine; Aged; Chemoradiotherapy; Double-Blind Method; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mouth Mucosa; Mouthwashes; Mucositis; Patient Reported Outcome Measures; Patient Safety; Pilot Projects; Prospective Studies; Quality of Life; Reference Values; Risk Assessment; Treatment Outcome; Xerostomia

2019

Other Studies

2 other study(ies) available for acetylcysteine and Mucositis

Article	Year
Investigation of the efficacy of systemic N-Acetyl Cysteine therapy preventing nasal mucositis following radiotherapy. Rhinology, 2023, Oct-01, Volume: 61, Issue:5 Topics: Acetylcysteine; Animals; Female; Humans; Mucositis; Nasal Mucosa; Quality of Life; Rats; Rats, Sprague-Dawley	2023
Regulation of HMGB1 release protects chemoradiotherapy-associated mucositis. Mucosal immunology, 2019, Volume: 12, Issue:5 Topics: Acetylcysteine; Animals; Chemoradiotherapy; Disease Models, Animal; Female; Histones; HMGB1 Protein; Humans; Mice; Mouth Mucosa; Mucositis; Neoplasms; NF-kappa B; Organic Chemicals; Protective Agents; Protein Transport; Reactive Oxygen Species; Signal Transduction; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays	2019

Article

Year

Investigation of the efficacy of systemic N-Acetyl Cysteine therapy preventing nasal mucositis following radiotherapy.

Rhinology, 2023, Oct-01, Volume: 61, Issue:5

Topics: Acetylcysteine; Animals; Female; Humans; Mucositis; Nasal Mucosa; Quality of Life; Rats; Rats, Sprague-Dawley

2023

Regulation of HMGB1 release protects chemoradiotherapy-associated mucositis.

Mucosal immunology, 2019, Volume: 12, Issue:5

Topics: Acetylcysteine; Animals; Chemoradiotherapy; Disease Models, Animal; Female; Histones; HMGB1 Protein; Humans; Mice; Mouth Mucosa; Mucositis; Neoplasms; NF-kappa B; Organic Chemicals; Protective Agents; Protein Transport; Reactive Oxygen Species; Signal Transduction; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2019